Articles Vol. 65 No. CĐ 3 - Bệnh viện Phổi Trung ương 15/05/2024

26. CLINICAL FEATURES AND RISK FACTORS OF PATIENTS WITH INVASIVE PULMONARY ASPERGILLOSIS AT NATIONAL LUNG HOSPITAL FROM 2019 TO 2020

Khuat Thi Luong1,2, Nguyen Thi Bich Ngoc1,2, Mai Manh Tu1,2
1 National Lung Hospital
2 Bệnh viện Phổi Trung ương
Corresponding author: Luongkhuat.dr@gmail.com
DOI: 10.52163/yhc.v65iCD3.1122
15 Views
9 Downloads
Abstract

Objective: To describe the clinical features and risk factors of patients with invasive pulmonary Aspergillosis treated at the National Lung Hospital.

Methods: Retrospective descriptive study on 47 patients with invasive pulmonary Aspergillosis, treated at the National Lung Hospital from January 2019 to December 2020.

Results: The average age was 54 ± 14 years old, 59.6% were 18-60 years olds, male/female was 2/1. The most common reasons for being hospitalized are breathless (48.9%) and fever (17%). However, the earliest symptoms of the disease appear 1-3 weeks before admission: Fever (40.4%) and phlegm cough (40.4%). 30/47 (63.8%) patients had host factors for EORTC/ MSG, mainly hematological malignancies (34%) and long-term corticosteroid use (23.4%). Other co-morbidities are diabetes (34%), hypertension (10.6%), and chronic hepatitis (14.9%).

Conclusion: Clinical features of invasive pulmonary Aspergillosis are multiform and non-specific, you have to think about fungal infection in patients with risk factors and have persistent respiratory symptoms that do not improve with common treatment.

References
[1]
Bongomin F, Gago S, Oladele RO et al., Global Google Scholar
[2]
and Multi-National Prevalence of Fungal Diseases— Google Scholar
[3]
Estimate Precision. J Fungi.3(4), 2017. Google Scholar
[4]
Smith JA, Kauffman CA, Pulmonary fungal Google Scholar
[5]
infections. Respirology. 17(6):913-926, 2012. Google Scholar
[6]
De Pauw B, Walsh TJ, Donnelly JP et al., Revised Google Scholar
[7]
Definitions of Invasive Fungal Disease Google Scholar
[8]
from the European Organization for Research Google Scholar
[9]
and Treatment of Cancer/Invasive Fungal Infections Google Scholar
[10]
Cooperative Group and the National Institute of Google Scholar
[11]
Allergy and Infectious Diseases Mycoses Google Scholar
[12]
Study Group (EORTC/MSG) Consensus Group. Google Scholar
[13]
Clin Infect Dis.46(12):1813-1821, 2008. Google Scholar
[14]
Webb BJ, Ferraro JP, Rea S et al., Epidemiology Google Scholar
[15]
and Clinical Features of Invasive Fungal Infection in Google Scholar
[16]
a US Health Care Network. Open Forum Google Scholar
[17]
Infect Dis.5(8), 2018. Google Scholar
[18]
Nguyễn Thị Như Quỳnh, Đặc điểm lâm sàng, Google Scholar
[19]
cận lâm sàng và kết quả điều trị nấm phổi xâm Google Scholar
[20]
lấn tại Trung tâm Hô hấp Bệnh viện Bạch Mai. Google Scholar
[21]
Luận văn thạc sĩ Đại học Y Hà Nội, 2018. Google Scholar
[22]
Tong KB, Lau CJ, Murtagh K et al., The economic Google Scholar
[23]
impact of aspergillosis: Analysis of hospital expenditures Google Scholar
[24]
across patient subgroups. Int J Infect Dis.13(1):24-36, Google Scholar
[25]
Segal BH, Walsh TJ, Current Approaches to Google Scholar
[26]
Diagnosis and Treatment of Invasive Aspergillosis. Google Scholar
[27]
Am J Respir Crit Care Med.173(7):707-717, 2006. Google Scholar